Watch Ticker

iBio, Inc.

Go to iBio, Inc. Website

$0.62

-0.01 (-1.61%)

Live

Previous Close

$0.6333

Day Range

$0.6213 - $0.6479

Previous Day Range

$0.63 - $0.66

Market Cap

$10.7 million USD

Day Vol.

385314

Previous Day Vol.

435671

Currency

USD

Primary Exchange

NYSE American, LLC

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing A...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

iBio and AstralBio have developed a novel amylin receptor agonist antibody that significantly reduced acute food intake in a mouse model of obesity, comparable to a leading amylin peptide agonist. The findings support the potential of antibody-based agonists to address the growing demand for safer, longer-acting treatments for obesity and cardiometabolic diseases.

Related tickers: IBIO.

Read Full Article

N/A - iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio

iBio has in-licensed a potentially best-in-class long-acting anti-myostatin antibody from AstralBio and is launching a new program featuring a myostatin + activin A bispecific antibody designed to promote weight loss, prevent muscle loss and weight regain.

Related tickers: IBIO.

Read Full Article

Trending Tickers

Please sign in to view